Document Detail

Combined iron/folic acid supplements and malaria prophylaxis reduce neonatal mortality in 19 sub-Saharan African countries.
MedLine Citation:
PMID:  20504976     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: In nonmalaria regions, iron/folic acid supplementation during pregnancy protects newborns against preterm delivery and early neonatal death. Other studies from malaria-endemic areas have reported an adverse effect of iron supplements on malaria prevalence in pregnant women. OBJECTIVE: We examined the association between iron/folic acid supplements and prenatal antimalaria prophylaxis on neonatal mortality in malaria-endemic countries of sub-Saharan Africa. DESIGN: This analysis used the most recent data from Demographic and Health Surveys of 19 malaria-endemic countries in sub-Saharan Africa. Survival information of 101,636 singleton live-born infants from the most recent delivery of ever-married women < or =5 y before each survey was examined. The effect of each potential predictor on neonatal deaths was analyzed by using Cox proportional hazards regression models. RESULTS: Infants whose mothers received any iron/folic acid supplements and sulfadoxine-pyrimethamine intermittent preventive treatment (SP-IPT(p)) for malaria during pregnancy were significantly protected from neonatal death [hazard ratio (HR): 0.76; 95% CI: 0.58, 0.99]. The protective effect was not significant in mothers who received only iron/folic acid supplements (HR: 0.90; 95% CI: 0.73, 1.12) or only SP-IPT(p) (HR: 1.08; 95% CI: 0.74, 1.57). Among the sociodemographic and birth characteristics, factors that significantly increased the risk of neonatal death included first-born infants, a birth interval of <2 y, maternal age at delivery of > or =30 y, smaller than average-sized infants, and male infants. CONCLUSION: The use of antenatal iron/folic acid supplements combined with appropriate intermittent preventive treatment of malaria during pregnancy is an important intervention to reduce neonatal mortality in malaria-endemic regions.
Christiana R Titaley; Michael J Dibley; Christine L Roberts; Kingsley Agho
Related Documents :
682326 - Screening and prevention of nutritional anemia during infancy. a prospective study of f...
3950826 - Nutrient retention in preterm infants fed standard infant formulas.
10653336 - Familial neonatal sids revealing carnitine-acylcarnitine translocase deficiency.
16922496 - The "bridging" aspartate 178 in phthalate dioxygenase facilitates interactions between ...
23056846 - A case of lipoid congenital adrenal hyperplasia presenting with cholestasis.
22925396 - The canadian birth place study: describing maternity practice and providers' exposure t...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-26
Journal Detail:
Title:  The American journal of clinical nutrition     Volume:  92     ISSN:  1938-3207     ISO Abbreviation:  Am. J. Clin. Nutr.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-21     Completed Date:  2010-07-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376027     Medline TA:  Am J Clin Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  235-43     Citation Subset:  AIM; IM    
Sydney School of Public Health, University of Sydney, Sydney, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Africa South of the Sahara / epidemiology
Child Health Services / standards
Delivery of Health Care / standards
Dietary Supplements
Folic Acid / therapeutic use*
Health Surveys
Infant Mortality / trends*
Infant, Newborn
Iron / therapeutic use*
Malaria / prevention & control*
Maternal Health Services / standards
Reg. No./Substance:
59-30-3/Folic Acid; 7439-89-6/Iron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Puberty and observed energy intake: boy, can they eat!
Next Document:  Effects of glycemic load on metabolic risk markers in subjects at increased risk of developing metab...